Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 6 % |
3 Month Return | -15.16 % |
1 Year Return | + 25.48 % |
Market Stats | |
Previous Close | ₹57.97 |
Open | ₹58.96 |
Volume | 9,542.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹158.89Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹158.89 Cr |
P/B Ratio | 0.98 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 3.74 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹158.89 Cr | 6.75% | 0.60 | NA | NA | |
NA | ₹435.76 Cr | 272.24% | 0.54 | ₹28 Cr | ₹601 Cr | |
NA | ₹15.41 Cr | 278.33% | 0.50 | NA | NA | |
BUY | ₹23,100.09 Cr | 3.59% | 0.52 | NA | NA | |
NA | ₹706.49 Cr | -0.07% | 0.57 | ₹9 Cr | ₹179 Cr |
Organisation | Aarey Drugs & Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Aarey Drugs & Pharmaceuticals Ltd
Aarey Drugs & Pharmaceuticals Ltd's Debt Levels Not Problematic - 22 Mar, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 51.33% to 51.81% in Sep 2024 quarter
Promoter Holding Up
Promoters have increased holdings from 45.28% to 45.44% in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 85.0%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 57.1% return, outperforming this stock by 37.3%
FII Holding Down
Foreign Institutions have decreased holdings from 3.40% to 2.75% in Sep 2024 quarter
Price Dip
In the last 7 days, AAREYDRUGS stock has moved down by -5.3%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 45.44% | 0.36 | |
Foreign Institutions | 2.75% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 51.81% | 0.94 | |
Others | 0% | 0.00 |
Aarey Drugs & Pharmaceuticals Ltd’s net profit jumped 30.08% since last year same period to ₹1.60Cr in the Q2 2024-2025. On a quarterly growth basis, Aarey Drugs & Pharmaceuticals Ltd has generated 29.03% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending September 2018, Aarey Drugs & Pharmaceuticals Ltd has declared dividend of ₹0.10 - translating a dividend yield of 0.17%.
Read More about DividendsBearish
Neutral
Bullish
Aarey Drugs & Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) share price today is ₹58.96
Aarey Drugs & Pharmaceuticals Ltd is listed on NSE
Aarey Drugs & Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) is 9,542.00.
Today’s market capitalisation of Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) is ₹158.89Cr.
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS | Price |
---|---|
52 Week High | ₹74.8 |
52 Week Low | ₹37.35 |
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) share price is ₹58.96. It is down -21.18% from its 52 Week High price of ₹74.8
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS) share price is ₹58.96. It is up 57.86% from its 52 Week Low price of ₹37.35
Aarey Drugs & Pharmaceuticals Ltd(AAREYDRUGS | Returns |
---|---|
1 Day Returns | 0.99% |
1 Month Returns | 6% |
3 Month Returns | -15.16% |
1 Year Returns | 25.48% |